Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
22.50
-1.70 (-7.02%)
Nov 20, 2024, 4:00 PM EST - Market closed
Septerna Revenue
Septerna had revenue of $687.00K in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to $838.00K. In the year 2023, Septerna had annual revenue of $151.00K.
Revenue (ttm)
$838.00K
Revenue Growth
n/a
P/S Ratio
52.42
Revenue / Employee
$12,324
Employees
68
Market Cap
945.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 151.00K | - | - |
Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSEPN News
- 1 day ago - Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 1 day ago - Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones - Benzinga
- 21 days ago - Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering - GlobeNewsWire
- 26 days ago - U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
- 26 days ago - Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut - Reuters
- 27 days ago - Septerna Prices Upsized Initial Public Offering - GlobeNewsWire
- 27 days ago - Goldman-backed drug developer Septerna targets $743 mln valuation in upsized US IPO - Reuters
- 4 weeks ago - Biotech Septerna aims to raise up to $186 million in US IPO - Reuters